secwatch.observer — SEC 8-K summary
======================================

Issuer:     Royalty Pharma plc (RPRX)
CIK:        0001802768
Form:       8-K
Filed at:   2024-06-06T23:59:59+00:00
Accession:  0001193125-24-156183
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Royalty Pharma shareholders elect all eight directors at June 6 AGM; all proposals pass
--------------------------------------------------------------------------------

- All eight director nominees elected with 457M–482M For votes; broker non-votes 24.8M per nominee.
- Advisory say-on-pay approved (448.1M For, 37.7M Against); auditor Ernst & Young LLP ratified (510.5M For).
- UK statutory accounts, directors' remuneration policy and report all passed with majority support.
- Share allotment authorities (proposals 9 & 10) approved with over 455M For votes each.
- Quorum of 85.49% of combined voting power represented at the meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1802768/000119312524156183/0001193125-24-156183-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1802768/000119312524156183/d843058d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-156183

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer